Literature DB >> 21393492

Chronic kidney disease as a coronary disease equivalent--a comparison with diabetes over a decade.

Yalew T Debella1, Habtamu D Giduma, Robert P Light, Rajiv Agarwal.   

Abstract

BACKGROUND AND OBJECTIVES: Whether chronic kidney disease (CKD) should also be considered a coronary disease equivalent like diabetes is not clear. DESIGN, SETTING, PARTICIPANTS, &
METHODS: Veterans with and without diabetes and with and without CKD were prospectively recruited. A competing Cox regression model was used to describe the risk of myocardial infarction (MI) in the two groups (CKD and diabetes) over a decade of follow-up.
RESULTS: The incidence rate of MI in those without CKD was 0.047/yr and in those with CKD was 0.206/yr. Multivariate adjustment revealed the incident rate ratio for MI in CKD as 3.5 and for diabetes mellitus as 2.5. The cumulative incidence for MI was influenced by CKD and diabetes. CKD was associated with a subhazard ratio for MI of 3.74; in contrast, diabetes was associated with a subhazard ratio for MI of 2.6. For the outcome of all-cause mortality, after multivariate adjustment, CKD was associated with a hazard ratio (HR) of 1.86, which was similar to the HR of 2.27 for prevalent coronary artery disease. The HR for diabetes was NS at 1.35.
CONCLUSIONS: CKD is associated with a risk of death similar to that of established coronary artery disease and higher than that of diabetes mellitus. CKD is associated with a risk of MI that is at least as much as that from diabetes mellitus. Among veterans, CKD appears to be a coronary disease equivalent.

Entities:  

Mesh:

Year:  2011        PMID: 21393492      PMCID: PMC3109936          DOI: 10.2215/CJN.10271110

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  24 in total

1.  Cardiovascular disease and chronic renal disease: a new paradigm.

Authors:  M J Sarnak; A S Levey
Journal:  Am J Kidney Dis       Date:  2000-04       Impact factor: 8.860

Review 2.  Prediction equations to estimate glomerular filtration rate: an update.

Authors:  G Manjunath; M J Sarnak; A S Levey
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-11       Impact factor: 2.894

3.  Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management.

Authors:  Scott M Grundy; Barbara Hansen; Sidney C Smith; James I Cleeman; Richard A Kahn
Journal:  Circulation       Date:  2004-02-03       Impact factor: 29.690

4.  Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Authors:  J F Mann; H C Gerstein; J Pogue; J Bosch; S Yusuf
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

5.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

6.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 8.  Study of Heart and Renal Protection (SHARP).

Authors:  Colin Baigent; Martin Landry
Journal:  Kidney Int Suppl       Date:  2003-05       Impact factor: 10.545

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

10.  National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events.

Authors:  George Bakris; Joseph Vassalotti; Eberhard Ritz; Christoph Wanner; George Stergiou; Mark Molitch; Richard Nesto; George A Kaysen; James R Sowers
Journal:  Kidney Int       Date:  2010-08-18       Impact factor: 10.612

View more
  21 in total

1.  Off-pump versus on-pump coronary artery bypass grafting outcomes stratified by preoperative renal function.

Authors:  Lakhmir S Chawla; Yue Zhao; Fredrick C Lough; Elizabeth Schroeder; Michael G Seneff; J Matthew Brennan
Journal:  J Am Soc Nephrol       Date:  2012-05-17       Impact factor: 10.121

2.  Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy.

Authors:  You-qun Huang; Rong Gou; Yong-shu Diao; Qing-hua Yin; Wen-xing Fan; Ya-ping Liang; Yi Chen; Min Wu; Li Zang; Ling Li; Jing Zang; Lu Cheng; Ping Fu; Fang Liu
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

3.  Mitochondrial ROS deficiency and diabetic complications: AMP[K]-lifying the adaptation to hyperglycemia.

Authors:  Dwight A Towler
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

4.  Arteriosclerosis, bone biology, and calciotropic hormone signaling: learning the ABCs of disease in the bone-vascular axis.

Authors:  Dwight A Towler
Journal:  J Am Soc Nephrol       Date:  2014-09-17       Impact factor: 10.121

Review 5.  Thiazide Diuretics in Chronic Kidney Disease.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Curr Hypertens Rep       Date:  2015-03       Impact factor: 5.369

6.  Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-13       Impact factor: 8.237

Review 7.  The complex relationship between CKD and ambulatory blood pressure patterns.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Adv Chronic Kidney Dis       Date:  2015-03       Impact factor: 3.620

8.  Hypertension Treatment for Patients with Advanced Chronic Kidney Disease.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Curr Cardiovasc Risk Rep       Date:  2014-10

9.  Chronic kidney disease: the "perfect storm" of cardiometabolic risk illuminates genetic diathesis in cardiovascular disease.

Authors:  Dwight A Towler
Journal:  J Am Coll Cardiol       Date:  2013-05-29       Impact factor: 24.094

10.  Matrix gla protein gene polymorphism is associated with increased coronary artery calcification progression.

Authors:  Andrea E Cassidy-Bushrow; Lawrence F Bielak; Albert M Levin; Patrick F Sheedy; Stephen T Turner; Eric Boerwinkle; Xihong Lin; Sharon L R Kardia; Patricia A Peyser
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-10       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.